ENALAPRILAT (enalaprilat) by Dr. Reddy's Laboratories is mechanism of action intravenous enalaprilat, or oral enalapril, after hydrolysis to enalaprilat, inhibits ace in human subjects and animals. Approved for hypertension. First approved in 2000.
Drug data last refreshed 18h ago
Mechanism of Action Intravenous enalaprilat, or oral enalapril, after hydrolysis to enalaprilat, inhibits ACE in human subjects and animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates…
Worked on ENALAPRILAT at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.